New skin gel offers hope for chemo pain without addiction risk
NCT ID NCT07072468
Summary
This study is testing a new gel applied to the skin to reduce pain caused by nerve damage from chemotherapy. Sixteen adults with stable, moderate nerve pain will try both the active gel and a placebo gel in different periods to see which works better. The gel is designed to calm overactive nerves locally, with minimal absorption into the bloodstream, aiming to relieve pain without the risks of addiction or interfering with other medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hammersmith Medicines Research Ltd (HMR code 24-503)
RECRUITINGLondon, UK, NW10 7EW, United Kingdom
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.